BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9469628)

  • 1. The INR: a perspective.
    Smith RE
    Semin Thromb Hemost; 1997; 23(6):547-9. PubMed ID: 9469628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
    Horsti J
    Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
    Gouin I; Horellou MH; Conard J; Samama M
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential failure of the International Normalized Ratio (INR) System in the monitoring of oral anticoagulation in patients with lupus anticoagulants.
    Della Valle P; Crippa L; Safa O; Tomassini L; Pattarini E; Vigano-D'Angelo S; Grazia Sabbadini M; D'Angelo A
    Ann Med Interne (Paris); 1996 Sep; 147 Suppl 1():10-4. PubMed ID: 8952752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does ISI of thromboplastin affect the INR value?
    Sitalakshmi S; Srikrishna A; Shanthala DA; Damodar P
    J Assoc Physicians India; 2005 May; 53():493-4. PubMed ID: 16124366
    [No Abstract]   [Full Text] [Related]  

  • 7. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current biological surveillance of oral anticoagulant treatment].
    Helft G; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1995 Jan; 88(1):85-9. PubMed ID: 7646254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of prothrombin time for laboratory control of oral anticoagulant therapy.
    Kitchen S; Preston FE
    Semin Thromb Hemost; 1999; 25(1):17-25. PubMed ID: 10327216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inter-institute variations in International Normalized Ratio and thrombotest].
    Nozawa T; Hayashi S; Naiki S; Niiya K; Asanoi H; Inoue H
    J Cardiol; 1998 Aug; 32(2):89-94. PubMed ID: 9752617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The factors that influence the consistency of international normalized ratio of prothrombin time].
    Su W; Ren FQ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Apr; 23(2):196-8. PubMed ID: 12905903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Quality control of ISI/INR system in oral anticoagulant therapy].
    Kazama M
    Rinsho Ketsueki; 1990 Jun; 31(6):769-75. PubMed ID: 2214167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of the treatment with oral anticoagulants and prothrombin time].
    Marzouka E
    Rev Med Chil; 1991 Oct; 119(10):1160-4. PubMed ID: 1845211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
    Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Oral anticoagulant therapy--renaissance of an old therapy?].
    Lechner K; Korninger C; Kyrle P; Geissler K; Niessner H; Pabinger I; Panzer S; Gössinger H; Bettelheim P; Hinterberger W
    Wien Klin Wochenschr; 1987 Apr; 99(7):203-10. PubMed ID: 3590801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
    Syrjälä M
    Duodecim; 1998; 114(6):573-5. PubMed ID: 11466922
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of Quick/INR values of whole capillary blood (CoaguChek Plus) and venous citrate plasma in patients with and without oral anticoagulation].
    Burri S; Demarmels Biasiutti F; Lämmle B; Wuillemin WA
    Schweiz Med Wochenschr; 1998 Oct; 128(44):1723-9. PubMed ID: 9846345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Present and future of oral anticoagulants].
    Meschengieser SS; Casais P; Sánchez Luceros A; Lazzari MA
    Medicina (B Aires); 2000; 60(1):139-42. PubMed ID: 10835711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
    Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Good therapy control requires a standardized test. Thrombosis ABC, 13: INR instead of Quick].
    Stiefelhagen P
    MMW Fortschr Med; 2000 Mar; 142(11):41. PubMed ID: 10786089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.